Study of Nivolumab (BMS-936558) Plus Ipilimumab Compared With Ipilimumab Alone in the Treatment of Previously Untreated, Unresectable, or Metastatic Melanoma
Clinical trial NCT01927419 · COMPLETED
Trial details
- NCT number
- NCT01927419
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-08-23
- Primary completion
- 2014-07-24
- Enrollment
- 142
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.